NEA
-
StartUPDATES: New Developments from Healthcare Startups
Read about news from Carrum Health, New Enterprise Associates, American Medical Women’s Association, and Iaso Therapeutics.
-
Investor insights: Blake Wu of NEA
In the runup to MedCity INVEST in Chicago, we’re spotlighting the perspectives of investors and what motivates them to invest in startups. If you’re a startup in pharma tech, value-based care and care coordination, diagnostics or remote patient monitoring/smart devices, apply to our Pitch Perfect contest today.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
INVEST Digital Health Pitch Perfect Preview: Home Health
Read more to find out which finalists will present in the Home Health track of the startup pitch contest during the virtual conference, scheduled for September 20-23.
-
Bright Health fuels expansion plans with $635M funding round
The insurance startup led by UnitedHealthcare’s former CEO closed a $635 million funding round led by New Enterprise Associates.
-
Investors offer pitching tips to healthcare startups in runup to INVEST Digital Health in Minneapolis
The deadline for applications to the Pitch Perfect competition at INVEST Digital Health in Minneapolis is approaching. Our judges for the contest offered their perspective for what makes or breaks a healthcare startup’s pitch.
-
Scott Gottlieb returns to NEA – this time with some valuable regulatory experience under his belt
Gottlieb previously worked at NEA from 2007 to 2017, when he was appointed as commissioner of the FDA. He stepped down from that role in March, also returning to another previous employer, the American Enterprise Institute.
-
Cleo raises $27.5M Series B to better support working parents
Big name executives including former GE CEO Jeff Immelt, former Yahoo CEO Marissa Mayer, LinkedIn CEO Jeff Weiner and Levi’s CEO Chip Bergh also made personal investments in the company as part of the Series B round led by NEA.
-
Healthcare analytics firm Aetion gets $27M from biopharma, healthcare companies
The company plans to the use the money to extend its reach into therapeutic area-related intelligence and outcomes-based contracting for payers.
-
Three “hits” on biopharma market trends at mcINVEST
From money-back guarantees to a surprising source of funding, MedCity INVEST presenters and panelists discussed some of the major trends influencing the biopharma sector in 2017.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
NEA’s Ed Mathers talks biopharma investment trends and why it’s worth sticking around
It’s safe to say Ed Mathers has accrued some industry know-how after 35 years in the biopharma industry — 15 of which have been spent on the investor side. So what’s his take on today’s high potential therapeutic areas?